< Back to results
 
Epilepsy, generalized with febrile seizures plus type 2 (deletion/duplication analysis on SCN1A gene)
SCN1A
Request Now


Methodology

Deletion/duplication analysis by MLPA


Specimen Requirements


Descriptive Volume /
Concentration 1
Container Transport
temperature
Sample
viability (days) 2
DNA ≥ 100 µL [50 ng/µL] Eppendorf Safe-lock Room temp. n/a
Fetal DNA ≥ 20 µL [25 ng/µL] Eppendorf Safe-lock Room temp. n/a
Peripheral blood ≥ 3 mL EDTA Room temp. 5
Amniotic fluid ≥ 5 mL Sterile tube Room temp. 4
Chorionic villus sampling (CVS) ≥ 30 mg Sterile tube + transport medium Room temp. 4
Cell culture 2 x T25 confluent Sterile tube + transport medium Room temp. 2
1 When it is not possible to collect the minimum volume for the test, please contact CGC Genetics
2 Maximum shipping time to ensure sample quality

Turnaround Time (Days)

- 30

CPT Codes

- 81407

Specialties

- Neurology / Neuropediatrics, Pediatrics


CGC Reference

- 865




Associated Tests


Severe myoclonic epilepsy of infancy - Dravet syndrome | Generalized epilepsy with febrile seizures plus type 2 | Familial hemiplegic migraine type 3 (sequence analysis of SCN1A gene)
Hemiplegic familial migraine (deletion/duplication analysis on SCN1A gene)
Central nervous system channelopathies (NGS panel of 23 genes)
Migraine (NGS panel of 9 genes)
Familial cerebral small vessel disease (NGS panel of 15 genes)